Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015:2015:725897.
doi: 10.1155/2015/725897. Epub 2015 Jun 16.

Isoflavone Attenuates the Caspase-1 and Caspase-3 Level in Cell Model of Parkinsonism

Jian-Xin Xu  1 , Hai-Ping Song  2 , Qing-Xia Bu  1 , De-Peng Feng  1 , Xiao-Fan Xu  1 , Qian-Ru Sun  3 , Xue-Li Li  1
Affiliations

Isoflavone Attenuates the Caspase-1 and Caspase-3 Level in Cell Model of Parkinsonism

Jian-Xin Xu et al. Behav Neurol. 2015.

Abstract

The study has investigated the effect of isoflavone attenuates the caspase-1 and caspase-3 level in cell model of Parkinsonism. The subjects were PC12 cells. They were randomly divided into six groups: control, MPP(+) (250 μmol/L), isoflavone (10 μM), isoflavone (10 μM) + MPP(+) (250 μmol/L), Z-YVAD-CHO (10 nM) + MPP(+) group, and Z-DEVD-CHO (10 nM) + MPP(+) group. Cell viability was measured by MTT methods; the content of tyrosine hydroxylase was measured by immunocytochemistry method of avidinbiotin peroxidase complex; apoptosis ratio was measured by flow cytometry. The results showed that cell viability in the MPP(+) group was lower than in all other five groups. There was no difference in cell viability between isoflavone + MPP(+) and control group. Optical density of TH positive cells in isoflavone group was higher than in control, isoflavone + MPP(+), and MPP(+) only groups. The apoptosis ratio in the isoflavone + MPP(+) group and control group and the Z-YVAD-CHO + MPP(+) and Z-DEVD-CHO + MPP(+) group was similar, which was lower than in the MPP(+) group. The lowest apoptosis ratio was found in the isoflavone only group.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Figure 2
Figure 2
See this image and copyright information in PMC

References

    1. Kalaiselvan V., Kalaivani M., Vijayakumar A., Sureshkumar K., Venkateskumar K. Current knowledge and future direction of research on soy isoflavones as a therapeutic agents. Pharmacognosy Reviews. 2010;4(8):111–117. - PMC - PubMed
    1. Qiang Q., Adachi H., Huang Z., et al. Genistein, a natural product derived from soybeans, ameliorates polyglutamine-mediated motor neuron disease. Journal of Neurochemistry. 2013;126(1):122–130. doi: 10.1111/jnc.12172. - DOI - PubMed
    1. Castelló-Ruiz M., Torregrosa G., Burguete M. C., et al. Soy-derived phytoestrogens as preventive and acute neuroprotectors in experimental ischemic stroke: influence of rat strain. Phytomedicine. 2011;18(6):513–515. doi: 10.1016/j.phymed.2011.02.001. - DOI - PubMed
    1. Li X.-L., Cheng W.-D., Li J., et al. Protective effect of estrogen on apoptosis in a cell culture model of Parkinson's disease. Clinical and Investigative Medicine. 2008;31(5):E258–E264. - PubMed
    1. Wang G., Zhou L., Zhang Y., et al. Implication of the c-Jun-NH2-terminal kinase pathway in the neuroprotective effect of puerarin against 1-methyl-4-phenylpyridinium (MPP+)-induced apoptosis in PC-12 cells. Neuroscience Letters. 2011;487(1):88–93. doi: 10.1016/j.neulet.2010.10.002. - DOI - PubMed

Publication types

LinkOut - more resources